Verilumia 
Sanofi and Regeneron Expand Drug Alliance, Settle Litigation
Sanofi and Regeneron said they have expanded their drug-development alliance to cover four experimental antibody programs, with Sanofi paying €1 billion upfront and potentially another €7 billion if the programs meet...
